Last Price Today's Change Day's Range Trading Volume 0.745 0.00 (0.00%) 0.74 - 0.75 5,075,300
Financials
Show? YoY % Horiz. %
Last 10 FY Result AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 3,826,428 6,232,868 12,445,628 10,603,755 9,709,721 6,846,085 6,297,658 5,415,744 5,111,822 4,946,091 4,495,141 3,992,722 13.46% YoY % -38.61% -49.92% 17.37% 9.21% 41.83% 8.71% 16.28% 5.95% 3.35% 10.03% 12.58% - Horiz. % 95.84% 156.11% 311.71% 265.58% 243.19% 171.46% 157.73% 135.64% 128.03% 123.88% 112.58% 100.00%
PBT -4,462,778 -3,571,460 -549,755 1,364,710 2,087,778 1,704,691 215,150 22,701 361,235 962,557 777,017 1,099,299 - YoY % -24.96% -549.65% -140.28% -34.63% 22.47% 692.33% 847.76% -93.72% -62.47% 23.88% -29.32% - Horiz. % -405.97% -324.89% -50.01% 124.14% 189.92% 155.07% 19.57% 2.07% 32.86% 87.56% 70.68% 100.00%
Tax 188,661 -10,846 263,792 346,695 -495,774 -86,133 326,130 60,135 889 -172,949 -221,693 -32,422 - YoY % 1,839.46% -104.11% -23.91% 169.93% -475.59% -126.41% 442.33% 6,664.34% 100.51% 21.99% -583.77% - Horiz. % -581.89% 33.45% -813.62% -1,069.32% 1,529.13% 265.66% -1,005.89% -185.48% -2.74% 533.43% 683.77% 100.00%
NP -4,274,117 -3,582,306 -285,963 1,711,405 1,592,004 1,618,558 541,280 82,836 362,124 789,608 555,324 1,066,877 - YoY % -19.31% -1,152.72% -116.71% 7.50% -1.64% 199.02% 553.44% -77.12% -54.14% 42.19% -47.95% - Horiz. % -400.62% -335.77% -26.80% 160.41% 149.22% 151.71% 50.73% 7.76% 33.94% 74.01% 52.05% 100.00%
NP to SH -3,541,634 -3,032,996 -303,722 1,979,972 1,639,649 1,621,659 541,194 82,836 362,124 789,608 555,324 1,066,877 - YoY % -16.77% -898.61% -115.34% 20.76% 1.11% 199.64% 553.33% -77.12% -54.14% 42.19% -47.95% - Horiz. % -331.96% -284.29% -28.47% 185.59% 153.69% 152.00% 50.73% 7.76% 33.94% 74.01% 52.05% 100.00%
Tax Rate - % - % - % -25.40 % 23.75 % 5.05 % -151.58 % -264.90 % -0.25 % 17.97 % 28.53 % 2.95 % - YoY % 0.00% 0.00% 0.00% -206.95% 370.30% 103.33% 42.78% -105,860.00% -101.39% -37.01% 867.12% - Horiz. % 0.00% 0.00% 0.00% -861.02% 805.08% 171.19% -5,138.30% -8,979.66% -8.47% 609.15% 967.12% 100.00%
Total Cost 8,100,545 9,815,174 12,731,591 8,892,350 8,117,717 5,227,527 5,756,378 5,332,908 4,749,698 4,156,483 3,939,817 2,925,845 17.74% YoY % -17.47% -22.91% 43.17% 9.54% 55.29% -9.19% 7.94% 12.28% 14.27% 5.50% 34.66% - Horiz. % 276.86% 335.46% 435.14% 303.92% 277.45% 178.67% 196.74% 182.27% 162.34% 142.06% 134.66% 100.00%
Net Worth 1,169,690 1,169,690 4,444,825 6,216,071 6,383,170 6,623,478 4,461,542 4,528,367 5,002,502 4,863,050 4,029,621 3,620,748 2.30% YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.29% - Horiz. % 32.31% 32.31% 122.76% 171.68% 176.29% 182.93% 123.22% 125.07% 138.16% 134.31% 111.29% 100.00%
Dividend AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div - 0 - 401,036 - - - - - 500,199 138,952 - - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 259.98% 0.00% - Horiz. % 0.00% 0.00% 0.00% 288.61% 0.00% 0.00% 0.00% 0.00% 0.00% 359.98% 100.00% -
Div Payout % - % - % - % 20.25 % - % - % - % - % - % 63.35 % 25.02 % - % - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 153.20% 0.00% - Horiz. % 0.00% 0.00% 0.00% 80.94% 0.00% 0.00% 0.00% 0.00% 0.00% 253.20% 100.00% -
Equity AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 1,169,690 1,169,690 4,444,825 6,216,071 6,383,170 6,623,478 4,461,542 4,528,367 5,002,502 4,863,050 4,029,621 3,620,748 2.30% YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.29% - Horiz. % 32.31% 32.31% 122.76% 171.68% 176.29% 182.93% 123.22% 125.07% 138.16% 134.31% 111.29% 100.00%
NOSH 3,341,974 3,341,974 3,341,974 3,341,974 3,341,974 2,782,974 2,788,463 2,761,200 2,779,167 2,778,886 2,779,049 2,763,930 2.13% YoY % 0.00% 0.00% 0.00% 0.00% 20.09% -0.20% 0.99% -0.65% 0.01% -0.01% 0.55% - Horiz. % 120.91% 120.91% 120.91% 120.91% 120.91% 100.69% 100.89% 99.90% 100.55% 100.54% 100.55% 100.00%
Ratio Analysis AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -111.70 % -57.47 % -2.30 % 16.14 % 16.40 % 23.64 % 8.59 % 1.53 % 7.08 % 15.96 % 12.35 % 26.72 % - YoY % -94.36% -2,398.70% -114.25% -1.59% -30.63% 175.20% 461.44% -78.39% -55.64% 29.23% -53.78% - Horiz. % -418.04% -215.08% -8.61% 60.40% 61.38% 88.47% 32.15% 5.73% 26.50% 59.73% 46.22% 100.00%
ROE -302.78 % -259.30 % -6.83 % 31.85 % 25.69 % 24.48 % 12.13 % 1.83 % 7.24 % 16.24 % 13.78 % 29.47 % - YoY % -16.77% -3,696.49% -121.44% 23.98% 4.94% 101.81% 562.84% -74.72% -55.42% 17.85% -53.24% - Horiz. % -1,027.42% -879.88% -23.18% 108.08% 87.17% 83.07% 41.16% 6.21% 24.57% 55.11% 46.76% 100.00%
Per Share AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 114.50 186.50 372.40 317.29 290.54 246.00 225.85 196.14 183.93 177.99 161.75 144.46 11.09% YoY % -38.61% -49.92% 17.37% 9.21% 18.11% 8.92% 15.15% 6.64% 3.34% 10.04% 11.97% - Horiz. % 79.26% 129.10% 257.79% 219.64% 201.12% 170.29% 156.34% 135.77% 127.32% 123.21% 111.97% 100.00%
EPS -106.00 -90.75 -9.10 59.20 49.10 58.30 19.40 3.00 13.00 28.40 20.00 38.60 - YoY % -16.80% -897.25% -115.37% 20.57% -15.78% 200.52% 546.67% -76.92% -54.23% 42.00% -48.19% - Horiz. % -274.61% -235.10% -23.58% 153.37% 127.20% 151.04% 50.26% 7.77% 33.68% 73.58% 51.81% 100.00%
DPS 0.00 0.00 0.00 12.00 0.00 0.00 0.00 0.00 0.00 18.00 5.00 0.00 - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 260.00% 0.00% - Horiz. % 0.00% 0.00% 0.00% 240.00% 0.00% 0.00% 0.00% 0.00% 0.00% 360.00% 100.00% -
NAPS 0.3500 0.3500 1.3300 1.8600 1.9100 2.3800 1.6000 1.6400 1.8000 1.7500 1.4500 1.3100 0.17% YoY % 0.00% -73.68% -28.49% -2.62% -19.75% 48.75% -2.44% -8.89% 2.86% 20.69% 10.69% - Horiz. % 26.72% 26.72% 101.53% 141.98% 145.80% 181.68% 122.14% 125.19% 137.40% 133.59% 110.69% 100.00%
Adjusted Per Share Value based on latest NOSH - 3,341,974 AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 114.50 186.50 372.40 317.29 290.54 204.85 188.44 162.05 152.96 148.00 134.51 119.47 13.46% YoY % -38.61% -49.92% 17.37% 9.21% 41.83% 8.71% 16.29% 5.94% 3.35% 10.03% 12.59% - Horiz. % 95.84% 156.11% 311.71% 265.58% 243.19% 171.47% 157.73% 135.64% 128.03% 123.88% 112.59% 100.00%
EPS -106.00 -90.75 -9.10 59.20 49.10 48.52 16.19 2.48 10.84 23.63 16.62 31.92 - YoY % -16.80% -897.25% -115.37% 20.57% 1.20% 199.69% 552.82% -77.12% -54.13% 42.18% -47.93% - Horiz. % -332.08% -284.30% -28.51% 185.46% 153.82% 152.01% 50.72% 7.77% 33.96% 74.03% 52.07% 100.00%
DPS 0.00 0.00 0.00 12.00 0.00 0.00 0.00 0.00 0.00 14.97 4.16 0.00 - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 259.86% 0.00% - Horiz. % 0.00% 0.00% 0.00% 288.46% 0.00% 0.00% 0.00% 0.00% 0.00% 359.86% 100.00% -
NAPS 0.3500 0.3500 1.3300 1.8600 1.9100 1.9819 1.3350 1.3550 1.4969 1.4551 1.2058 1.0834 2.30% YoY % 0.00% -73.68% -28.49% -2.62% -3.63% 48.46% -1.48% -9.48% 2.87% 20.68% 11.30% - Horiz. % 32.31% 32.31% 122.76% 171.68% 176.30% 182.93% 123.22% 125.07% 138.17% 134.31% 111.30% 100.00%
Price Multiplier on Financial Quarter End Date AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 0.6700 0.6700 1.7000 2.9700 3.3500 2.2900 1.2900 2.7200 2.2000 2.7400 3.7700 2.5300 -
P/RPS 0.59 0.36 0.46 0.94 1.15 0.93 0.57 1.39 1.20 1.54 2.33 1.75 -13.79% YoY % 63.89% -21.74% -51.06% -18.26% 23.66% 63.16% -58.99% 15.83% -22.08% -33.91% 33.14% - Horiz. % 33.71% 20.57% 26.29% 53.71% 65.71% 53.14% 32.57% 79.43% 68.57% 88.00% 133.14% 100.00%
P/EPS -0.63 -0.74 -18.71 5.01 6.83 3.93 6.65 90.67 16.88 9.64 18.87 6.55 - YoY % 14.86% 96.04% -473.45% -26.65% 73.79% -40.90% -92.67% 437.14% 75.10% -48.91% 188.09% - Horiz. % -9.62% -11.30% -285.65% 76.49% 104.27% 60.00% 101.53% 1,384.27% 257.71% 147.18% 288.09% 100.00%
EY -158.17 -135.45 -5.35 19.95 14.65 25.45 15.05 1.10 5.92 10.37 5.30 15.26 - YoY % -16.77% -2,431.78% -126.82% 36.18% -42.44% 69.10% 1,268.18% -81.42% -42.91% 95.66% -65.27% - Horiz. % -1,036.50% -887.61% -35.06% 130.73% 96.00% 166.78% 98.62% 7.21% 38.79% 67.96% 34.73% 100.00%
DY 0.00 0.00 0.00 4.04 0.00 0.00 0.00 0.00 0.00 6.57 1.33 0.00 - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 393.98% 0.00% - Horiz. % 0.00% 0.00% 0.00% 303.76% 0.00% 0.00% 0.00% 0.00% 0.00% 493.98% 100.00% -
P/NAPS 1.91 1.91 1.28 1.60 1.75 0.96 0.81 1.66 1.22 1.57 2.60 1.93 -4.46% YoY % 0.00% 49.22% -20.00% -8.57% 82.29% 18.52% -51.20% 36.07% -22.29% -39.62% 34.72% - Horiz. % 98.96% 98.96% 66.32% 82.90% 90.67% 49.74% 41.97% 86.01% 63.21% 81.35% 134.72% 100.00%
Price Multiplier on Announcement Date AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 27/02/20 27/02/19 27/02/18 23/02/17 26/02/16 26/02/15 26/02/14 26/02/13 22/02/12 24/02/11 -
Price 0.7100 0.7100 1.1100 3.0400 4.4600 2.7600 1.3900 2.7000 2.3800 2.6400 3.6500 2.3500 -
P/RPS 0.62 0.38 0.30 0.96 1.54 1.12 0.62 1.38 1.29 1.48 2.26 1.63 -17.13% YoY % 63.16% 26.67% -68.75% -37.66% 37.50% 80.65% -55.07% 6.98% -12.84% -34.51% 38.65% - Horiz. % 38.04% 23.31% 18.40% 58.90% 94.48% 68.71% 38.04% 84.66% 79.14% 90.80% 138.65% 100.00%
P/EPS -0.67 -0.78 -12.21 5.13 9.09 4.74 7.16 90.00 18.27 9.29 18.27 6.09 - YoY % 14.10% 93.61% -338.01% -43.56% 91.77% -33.80% -92.04% 392.61% 96.66% -49.15% 200.00% - Horiz. % -11.00% -12.81% -200.49% 84.24% 149.26% 77.83% 117.57% 1,477.83% 300.00% 152.55% 300.00% 100.00%
EY -149.26 -127.82 -8.19 19.49 11.00 21.11 13.96 1.11 5.47 10.76 5.47 16.43 - YoY % -16.77% -1,460.68% -142.02% 77.18% -47.89% 51.22% 1,157.66% -79.71% -49.16% 96.71% -66.71% - Horiz. % -908.46% -777.97% -49.85% 118.62% 66.95% 128.48% 84.97% 6.76% 33.29% 65.49% 33.29% 100.00%
DY 0.00 0.00 0.00 3.95 0.00 0.00 0.00 0.00 0.00 6.82 1.37 0.00 - YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 397.81% 0.00% - Horiz. % 0.00% 0.00% 0.00% 288.32% 0.00% 0.00% 0.00% 0.00% 0.00% 497.81% 100.00% -
P/NAPS 2.03 2.03 0.83 1.63 2.34 1.16 0.87 1.65 1.32 1.51 2.52 1.79 -8.18% YoY % 0.00% 144.58% -49.08% -30.34% 101.72% 33.33% -47.27% 25.00% -12.58% -40.08% 40.78% - Horiz. % 113.41% 113.41% 46.37% 91.06% 130.73% 64.80% 48.60% 92.18% 73.74% 84.36% 140.78% 100.00%
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
ruby92 relax steady punpipi. steady boy 19/01/2021 8:49 PM
DickyMe Hi TripleH, It is struggling to reach it's hyped level above RM10. I can only feel pity for people who call themselves as investors but has herd mentality. 19/01/2021 9:00 PM
sharewiz118 ini AA still can terbang kah ? maybe bulan march can la because obat sudah mari 19/01/2021 9:53 PM
DickyMe Walaubagaimanapun, pandemik tidak akan kekal. Pembelian kecil-kecilan akan meningkatkan jumlah saham dalam pegangan. Lambat laun AA tetap akan terbang, ketika itu and akan ... KAYA..KAYA..KAYA...AKU...KAYA...KAYA..KAYA...AKU KAYA..KAYA...AKU. 19/01/2021 9:58 PM
sharewiz118 Tony F sudah dapat sugar mommy kah, hutang banyak kuat ohhhh... 19/01/2021 9:59 PM
sharewiz118 Jual belakang unta pun tak boleh habis bayar hutang lor 19/01/2021 10:02 PM
DickyMe Bulan Feb, up lagi! Kuota Jan sudah diisi. 19/01/2021 10:04 PM
sharewiz118 alright gua caya sama lu, tomorrow top up 1 more lot 19/01/2021 10:10 PM
Steady Punpipi How long Can AA lasts without bailout....only TF and Mahcai knows and for us to bleed out...last to know 19/01/2021 10:12 PM
sharewiz118 the facts is AA certainly in deep shit but share market are base on sentiment hence, when vaccine are release to the public certainly it'll bring hope to some of the counter like AA. It doesn't look good today but during month of march it could paint a different picture 19/01/2021 10:16 PM
DickyMe Business itself is based on sentiment or demand. 19/01/2021 10:59 PM
Expertise https://www.google.com/amp/s/amp.theguardian.com/business/2021/jan/19/holiday-bookings-surge-as-covid-vaccinations-increase-travel-hopes 19/01/2021 11:19 PM
Hoho22 Flight to Holland! 19/01/2021 11:26 PM
MoneyMakers UK vaccination progressing well..33K+ cases for Tuesday (Monday 37K, Sunday 38K) vs Jan high 60K cases 20/01/2021 12:11 AM
MoneyMakers US vaccination also accelerating - US daily new cases have also fallen from a peak of 283,204 on January 8 to 137,885 on Tuesday, January 19. The seven-day rolling average of 200,407 is the lowest figure since the new year. 20/01/2021 12:22 AM
ruby92 All country currently waiting the vaccine results from israel with 30% of their people has been vaccinate up to date. We will see the results by the end of feb when. 20/01/2021 2:58 AM
ruby92 Then we will be millionaires 20/01/2021 2:58 AM
ruby92 Damn I can’t sleep at night after my wife left me T_T 20/01/2021 2:59 AM
newbie4444 Border not open why good for AA? 20/01/2021 3:58 AM
newbie4444 74 sen AA cheap? Why TF not buying? 20/01/2021 3:59 AM
Woodswater https://www.nst.com.my/news/nation/2021/01/658855/mco-20-extension-tighter-sop-be-considered Good news! 20/01/2021 8:06 AM
MoneyMakers Israel alrdy vaccinate 70% people over 60..early/mid Feb should see better signs of immunity Israel will eventually publish their vaccination/testing results..real world results - highly anticipated 20/01/2021 9:22 AM
kingpuk91 bought at 0.55. should hold or collect? Thanks in advance all Sifus here 20/01/2021 9:35 AM
DickyMe "Posted by ruby92 > Jan 20, 2021 2:58 AM | Report Abuse All country currently waiting the vaccine results from israel with 30% of their people has been vaccinate up to date. We will see the results by the end of feb when." ======================================== The most important observation should be on any deaths caused by vaccine itself then concentrate on effectiveness of controlling or eradicating the virus. If the results are appreciable then recovery from pandemic is on its way. 20/01/2021 9:38 AM
TripleH You are right Dicky, the rm4 man! There's just no momentum for glove counter anymore no matter good news or good report! Better invest in the future! 20/01/2021 10:27 AM
sampooler https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/ 20/01/2021 10:43 AM
Woodswater kingpuk91 bought at 0.55. should hold or collect? Thanks in advance all Sifus here 20/01/2021 9:35 AM Covid-19 vaccine safe for those with chronic illness; women advised to defer conception for a month after jabs, says Singapore’s Health Ministry https://newswav.com/A2101_y4wPqO?s=A_36YmmU6 Singapore health Minister department also used as Asean guideline I matched 745 Happy to rejoin AA This time i hold long term No gimmicks! Wakakakaka 20/01/2021 11:03 AM
freifeit Relax relax relax... 20/01/2021 11:08 AM
perx135305 Look long term. The biggest risk in holding AA now is the chance of RI. 20/01/2021 12:23 PM
freifeit Institutions are still collecting AA shares today.. Just relax.. 20/01/2021 1:10 PM
MoneyMakers Gloves sure no hope alrdy, Supermx heading towards 5.0..even europe glove shares down - signal market optimistic on vaccination progress Future is recovery/tech/banks 20/01/2021 1:22 PM
Woodswater https://www.theedgemarkets.com/article/fernandes-airasia-not-cancelling-airbus-orders-moment Bad news! 20/01/2021 1:28 PM
ruby92 https://www.bloomberg.com/news/articles/2021-01-19/covid-cases-fall-in-all-regions-even-as-u-s-faces-400-000-dead?utm_campaign=socialflow-organic&cmpid=socialflow-facebook-business&utm_medium=social&utm_source=facebook&utm_content=business&fbclid=IwAR2O2WEmhFQtVP_sXXHpY8qVva9Kr75qgJgY9CLlcp6dVcSbBiTEDIZXiQE 20/01/2021 1:37 PM
ruby92 Vaccines are working. Let’s see what’s going to happened by end of feb hehehehe 20/01/2021 1:38 PM
ruby92 Relax brader brader relax. Mantap choii 20/01/2021 1:54 PM
Woodswater https://www.globaltimes.cn/page/202101/1213297.shtml Good news Wakakakaka 20/01/2021 2:34 PM
ykyew11 Norway's health regulator already came out to say that the deaths are not linked to the vaccine. Globaltimes is a chinese based news outlet, so obviously they have a vested interest to say that China's vaccines are safer or better than Pfizer. 20/01/2021 2:55 PM
ruby92 https://www.google.com.my/amp/s/mobile.reuters.com/article/amp/idUSR4N2HZ01X 20/01/2021 3:44 PM
ruby92 Another promising vaccine from russia wohoo 20/01/2021 3:44 PM
ruby92 we can go through this together hehe 20/01/2021 4:58 PM
Comment